Aadi Bioscience Q1 2024 GAAP EPS $(0.68) Misses $(0.65) Estimate, Sales $5.353M Miss $6.454M Estimate
Portfolio Pulse from Benzinga Newsdesk
Aadi Bioscience reported Q1 2024 earnings with a GAAP EPS of $(0.68), missing the $(0.65) estimate, and sales of $5.353M, below the $6.454M estimate. This represents a 8.76% decrease in sales compared to the same period last year.
May 08, 2024 | 12:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aadi Bioscience missed Q1 2024 earnings and sales estimates, with a significant decrease in sales compared to last year.
Missing both EPS and sales estimates, especially with a notable year-over-year decrease in sales, is likely to negatively impact investor sentiment and AADI's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100